Clinical Trial Update: Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy [Phase 1, Phase 2]

View source ↗

Summary

The document reports a Phase 1/Phase 2 clinical trial evaluating mesenchymal stem cell therapy for idiopathic dilated cardiomyopathy; the status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Dilated Cardiomyopathy

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Hospital General Universitario Gregorio Marañon | Conditions: Primary Idiopathic Dilated Cardiomyopathy | Phase 1, Phase 2 | Status: UNKNOWN